Title: Life‐threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria
Abstract: American Journal of HematologyVolume 83, Issue 11 p. 881-883 Correspondence and Letters to the EditorFree Access Life-threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria Bettina M. Knoll, Bettina M. Knoll Division of Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorLouis Letendre, Louis Letendre Division of Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorDavid P. Steensma, David P. Steensma Division of Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this author Bettina M. Knoll, Bettina M. Knoll Division of Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorLouis Letendre, Louis Letendre Division of Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorDavid P. Steensma, David P. Steensma Division of Hematology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this author First published: 19 August 2008 https://doi.org/10.1002/ajh.21265Citations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume83, Issue11November 2008Pages 881-883 ReferencesRelatedInformation
Publication Year: 2008
Publication Date: 2008-08-28
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 12
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot